TW202510910A - 疫苗佐劑組成物及其用途 - Google Patents

疫苗佐劑組成物及其用途 Download PDF

Info

Publication number
TW202510910A
TW202510910A TW113124406A TW113124406A TW202510910A TW 202510910 A TW202510910 A TW 202510910A TW 113124406 A TW113124406 A TW 113124406A TW 113124406 A TW113124406 A TW 113124406A TW 202510910 A TW202510910 A TW 202510910A
Authority
TW
Taiwan
Prior art keywords
vaccine
composition
antigen
polymer
adjuvant composition
Prior art date
Application number
TW113124406A
Other languages
English (en)
Chinese (zh)
Inventor
高橋宜聖
佐佐木永太
上下泰造
Takashi Miyazaki
池田千将
Miki Yamauchi
富岡聡子
Original Assignee
國立感染症研究所長代表之日本國
日商東興藥品工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立感染症研究所長代表之日本國, 日商東興藥品工業股份有限公司 filed Critical 國立感染症研究所長代表之日本國
Publication of TW202510910A publication Critical patent/TW202510910A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
TW113124406A 2023-06-28 2024-06-28 疫苗佐劑組成物及其用途 TW202510910A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-105990 2023-06-28
JP2023105990 2023-06-28

Publications (1)

Publication Number Publication Date
TW202510910A true TW202510910A (zh) 2025-03-16

Family

ID=93939172

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113124406A TW202510910A (zh) 2023-06-28 2024-06-28 疫苗佐劑組成物及其用途

Country Status (3)

Country Link
JP (1) JPWO2025005260A1 (https=)
TW (1) TW202510910A (https=)
WO (1) WO2025005260A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2707333B2 (ja) * 1989-08-09 1998-01-28 ライオン株式会社 点鼻用う蝕予防ワクチン組成物
JPH05132428A (ja) * 1991-11-11 1993-05-28 Lion Corp 点鼻用歯周病予防ワクチン
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2010114169A1 (en) * 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
EP2679242B1 (en) * 2011-02-25 2020-09-09 Hisamitsu Pharmaceutical Co., Inc. Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same
JP2018020962A (ja) * 2014-12-08 2018-02-08 エヌエーアイ株式会社 新規アジュバント
BR112018076015A8 (pt) * 2016-06-17 2022-06-28 Sanofi Pasteur Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado .
AU2022423668A1 (en) * 2021-12-20 2024-07-11 Japan Institute For Health Security Vaccine adjuvant agent containing polyacrylic acid polymer and use of same

Also Published As

Publication number Publication date
WO2025005260A1 (ja) 2025-01-02
JPWO2025005260A1 (https=) 2025-01-02

Similar Documents

Publication Publication Date Title
Zaman et al. Strategies for intranasal delivery of vaccines
JP2025107179A (ja) 治療に好適なｒｎａ製剤
Amidi et al. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model
JP6247639B2 (ja) 経鼻インフルエンザワクチン組成物
CN1097467C (zh) 疫苗组合物
Gupta et al. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza
Boonyo et al. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration
Tafaghodi et al. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN
JP2003522802A (ja) プロテオソーム・インフルエンザ・ワクチン
Davis The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery
Simón-Vázquez et al. Polymeric nanostructure vaccines: applications and challenges
WO2001017556A1 (fr) Préparations vaccinales administrables par les muqueuses
WO2017122635A1 (ja) 固定化ウイルス粒子を含むワクチン
RU2570394C2 (ru) Мукозальная вакцина
Jiang et al. Preparation and characterization of curdlan-chitosan conjugate nanoparticles as mucosal adjuvants for intranasal influenza H1N1 subunit vaccine
WO2023108083A3 (en) Nanoparticle immunogenic compositions and vaccination methods
KR20240122803A (ko) 폴리아크릴산 폴리머를 함유하는 백신 보조제 및 그의 사용
TW202510910A (zh) 疫苗佐劑組成物及其用途
EP1957101A2 (en) Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
EP3886896A1 (en) Oral dispersible vaccine comprising virosomes
Tian et al. A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine
HK40110537A (zh) 含有聚丙烯酸系聚合物的疫苗佐剂及其用途
JP7644514B2 (ja) 皮下投与型ワクチン
Sparks et al. Sustained release of inactivated H1N1 virus from degradable microparticles for extended vaccination
US20260000621A1 (en) Compositions and methods of use for stabilizing and delivery of atomic layer deposition coating of agent-containing lipid-emulsion formulations